Immune changes in peripheral blood resulting from locally directed interleukin-2 therapy in squamous cell carcinoma of the head and neckDADIAN, G; RICHES, P. G; HENDERSON, D. C et al.European journal of cancer. Part B, Oral oncology. 1993, Vol 29, Num 1, pp 29-34, issn 0964-1955Article

Combined detection of phenotype and Y chromosome by immunoenzyme labelling and in situ hyridisation on peripheral lymphocytesQIU WANG; ROWBOTTOM, A. W; RICHES, P. G et al.Journal of immunological methods. 1991, Vol 139, Num 2, pp 251-255, issn 0022-1759, 5 p.Article

Randomized phase II trial of BCDT [carmustine (BCNU), cisplatin, dacarbazine (DTIC) and tamoxifen] with or without interferon alpha (IFN-α) and interleukin (IL-2) in patients with metastatic melanomaJOHNSTON, S. R. D; CONSTENLA, D. O; MOORE, J et al.British journal of cancer. 1998, Vol 77, Num 8, pp 1280-1286, issn 0007-0920Article

Immunological parameters in peripheral blood of patients with renal cell carcinoma before and after nephrectomyDADIAN, G; RICHES, P. G; HENDERSON, D. C et al.British journal of urology (Print). 1994, Vol 74, Num 1, pp 15-22, issn 0007-1331Article

Increased soluble interleukin-2 receptor concentration in plasma predicts a decreased cellular response to IL-2GOODING, R; RICHES, P; DADIAN, G et al.British journal of cancer. 1995, Vol 72, Num 2, pp 452-455, issn 0007-0920Article

An analysis of the normal ranges of lymphocyte subpopulations in children aged 5-13 yearsROBINSON, M; O'DONOHOE, J; DADIAN, G et al.European journal of pediatrics. 1996, Vol 155, Num 7, pp 535-539, issn 0340-6199Article

Phase I study of intra-arterial interleukin-2 in squamous cell carcinoma of the head and neckGORE, M. E; RICHES, P; BREACH, N et al.British journal of cancer. 1992, Vol 66, Num 2, pp 405-407, issn 0007-0920Article

Plasma neopterin as an adjunct to C-reactive protein in assessment of infectionSHELDON, J; RICHES, P. G; SONI, N et al.Clinical chemistry (Baltimore, Md.). 1991, Vol 37, Num 12, pp 2038-2042, issn 0009-9147Article